ES2127263T3 - Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. - Google Patents
Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.Info
- Publication number
- ES2127263T3 ES2127263T3 ES93402372T ES93402372T ES2127263T3 ES 2127263 T3 ES2127263 T3 ES 2127263T3 ES 93402372 T ES93402372 T ES 93402372T ES 93402372 T ES93402372 T ES 93402372T ES 2127263 T3 ES2127263 T3 ES 2127263T3
- Authority
- ES
- Spain
- Prior art keywords
- chromenic
- trien
- derivatives
- contain
- new
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
COMPUESTOS DE FORMULA GENERAL (I), EN LA CUAL LAS AGRUPACIONES R1 A R8 SON TALES COMO DEFINIDAS EN LA DESCRIPCION. MEDICAMENTOS.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9211592A FR2696175B1 (fr) | 1992-09-29 | 1992-09-29 | Nouveaux dérivés chroméniques à chaîne triénique, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
FR9211591A FR2696174B1 (fr) | 1992-09-29 | 1992-09-29 | Nouveaux dérivés chroméniques à chaîne triénique diméthylée, leur procédé de préparation et les compositions pharmaceutiques les renfermant. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2127263T3 true ES2127263T3 (es) | 1999-04-16 |
Family
ID=26229758
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES93402372T Expired - Lifetime ES2127263T3 (es) | 1992-09-29 | 1993-09-29 | Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. |
Country Status (10)
Country | Link |
---|---|
US (1) | US5391569A (es) |
EP (1) | EP0591046B1 (es) |
JP (1) | JP2594409B2 (es) |
AT (1) | ATE174026T1 (es) |
AU (1) | AU658331B2 (es) |
CA (1) | CA2107150C (es) |
DE (1) | DE69322353T2 (es) |
DK (1) | DK0591046T3 (es) |
ES (1) | ES2127263T3 (es) |
NZ (1) | NZ248794A (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU726450B2 (en) | 1995-10-06 | 2000-11-09 | Ligand Pharmaceuticals Incorporated | Dimer-selective RXR modulators and methods for their use |
US5717106A (en) * | 1996-09-16 | 1998-02-10 | Eastman Kodak Company | Chromene dyes |
WO1999063980A1 (en) * | 1998-06-12 | 1999-12-16 | Ligand Pharmaceuticals Inc. | Treatment of anti-estrogen resistant breast cancer using rxr modulators |
FR2787789B1 (fr) * | 1998-12-29 | 2002-06-14 | Lipha | Benzopyranes et benzoxepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparations |
US6566372B1 (en) * | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
AU778655B2 (en) | 1999-08-27 | 2004-12-16 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
US6667313B1 (en) | 1999-08-27 | 2003-12-23 | Ligand Pharmaceuticals Inc. | 8-substituted-6-triflouromethyl-9-pyrido [3,2-G] quinoline compounds as androgen receptor modulators |
PE20010647A1 (es) | 1999-09-14 | 2001-06-23 | Lilly Co Eli | Moduladores de receptores de retinoide x (rxr) con perfil farmacologico mejorado |
US9050310B2 (en) * | 2004-06-25 | 2015-06-09 | Minas Theodore Coroneo | Treatment of ocular lesions |
US20060204474A1 (en) * | 2005-02-25 | 2006-09-14 | Coroneo Minas T | Treatment of epithelial layer lesions |
US8617801B2 (en) * | 2009-06-03 | 2013-12-31 | Carestream Health, Inc. | Film with blue dye |
US11045441B2 (en) | 2015-10-13 | 2021-06-29 | Wisconsin Alumni Research Foundation | Use of retinoic acid and analogs thereof to treat central neural apneas |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4544758A (en) * | 1982-06-29 | 1985-10-01 | Basf Aktiengesellschaft | Vitamin E intermediates and methods for the preparation of (2R,4'RS,8'RS)-α-tocopherol and (all-rac)-α-tocopherol via the new intermediate products |
FR2580277B1 (fr) * | 1985-04-15 | 1988-06-10 | Oreal | Nouveaux derives naphtaleniques a action retinoique, le ur procede de preparation et compositions medicamenteuse et cosmetique les contenant |
LU86388A1 (fr) * | 1986-04-04 | 1987-12-07 | Oreal | Nouveaux derives de chromane et du thiochromane,leur procede de preparation et compositions medicamenteuse et cosmetique les contenant |
FR2630111B1 (fr) * | 1988-04-13 | 1990-07-27 | Adir | Nouveaux derives trieniques de structure chromenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US5260294A (en) * | 1988-08-09 | 1993-11-09 | Hoffman-La Roche Inc. | Chromanes and their pharmaceutical compositions and methods |
US5045551A (en) * | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
-
1993
- 1993-09-28 US US08/127,804 patent/US5391569A/en not_active Expired - Fee Related
- 1993-09-28 JP JP5241617A patent/JP2594409B2/ja not_active Expired - Lifetime
- 1993-09-28 AU AU48616/93A patent/AU658331B2/en not_active Ceased
- 1993-09-28 CA CA002107150A patent/CA2107150C/fr not_active Expired - Fee Related
- 1993-09-28 NZ NZ248794A patent/NZ248794A/xx unknown
- 1993-09-29 DE DE69322353T patent/DE69322353T2/de not_active Expired - Fee Related
- 1993-09-29 EP EP93402372A patent/EP0591046B1/fr not_active Expired - Lifetime
- 1993-09-29 DK DK93402372T patent/DK0591046T3/da active
- 1993-09-29 ES ES93402372T patent/ES2127263T3/es not_active Expired - Lifetime
- 1993-09-29 AT AT93402372T patent/ATE174026T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE174026T1 (de) | 1998-12-15 |
AU658331B2 (en) | 1995-04-06 |
US5391569A (en) | 1995-02-21 |
CA2107150C (fr) | 2001-10-23 |
CA2107150A1 (fr) | 1994-03-30 |
AU4861693A (en) | 1994-04-14 |
DE69322353T2 (de) | 1999-06-24 |
DE69322353D1 (de) | 1999-01-14 |
DK0591046T3 (da) | 1999-08-16 |
EP0591046B1 (fr) | 1998-12-02 |
JPH06211829A (ja) | 1994-08-02 |
NZ248794A (en) | 1995-01-27 |
JP2594409B2 (ja) | 1997-03-26 |
EP0591046A1 (fr) | 1994-04-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR005703A1 (es) | Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen | |
ES2095432T3 (es) | Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
SE8602723L (sv) | Tiazoler, deras framstellning och farmaceutiska kompositioner innehallande dem | |
MX9204354A (es) | Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen. | |
ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
MX9300407A (es) | Derivados azabiciclicos usados en la fabricacion de medicamentos, composiciones que los contienen y procedimiento para su preparacion. | |
ES2058504T3 (es) | Derivados de piperidina y piperazina, procedimiento para preparar los mismos, y composiciones farmaceuticas que contienen los mismos. | |
ES2128519T3 (es) | Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen. | |
ES2127263T3 (es) | Nuevos trien-derivados cromenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
MX9300628A (es) | Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
ES2148458T3 (es) | Derivados de fenil-4-tiazoles sustituidos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
AR001813A1 (es) | Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen | |
MX9304355A (es) | Compuestos heterociclicos. | |
ES2160308T3 (es) | Nuevos derivados amino-metil-heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2125963T3 (es) | Nuevos derivados espiranicos del 3-amino-cromano, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
AR007297A1 (es) | Un compuesto derivado de 5-aroil-pirrol-2-ilmetilareno, medicamentos y composiciones farmaceuticas que lo contienen y usos del mismo. | |
ES2104917T3 (es) | Bis-naftalimidas que contienen engarces amido y tioamido como agentes anticancerosos. | |
MX9300406A (es) | Derivados azabiciclicos procedimientos para su preparacion y composiciones que los contienen. | |
ES2086195T3 (es) | Nuevos derivados pseudopeptidicos de actividad antagonista de la bradiquinina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
SE8306225L (sv) | 2-piperazinyl-kinazolinderivat, deras framstellning och farmaceutiska kompositioner innehallande desamma | |
IT8948610A0 (it) | Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono | |
MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. | |
MX9400072A (es) | Agentes antiinflamatorios derivados de difluoropentapeptido. | |
ES2124267T3 (es) | Derivados macrolidas de 16 eslabones con una actividad antibacteriana prolongada en el plasma, intermediarios de sintesis y procedimiento de preparacion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 591046 Country of ref document: ES |